Inventor · disambiguated record
Keng-Li Lan
Also filed as: LAN KENG-LI
7 granted patents·3 pending applications·29 citations·filing 2003–2023
80Inventor score
Files withTAIPEI VETERANS GENERAL HOSPITAL3LAN KENG LI2UNIV TEXAS2FULLHOPE BIOMEDICAL CO LTD1LAN KENG-HSIN1
Top patents by PatentIndex Score
10 records- 0187US8609625B2Method for enhancing immune response in the treatment of infectious and malignant diseasesLAN KENG-LI·Filed 2012·Granted Dec 17, 2013·14 cites·6 claims
- 0284US9289480B2Method for enhancing immune response in the treatment of infectious and malignant diseasesTAIPEI VETERANS GENERAL HOSPITAL·Filed 2013·Granted Mar 22, 2016·9 cites·4 claims
- 0376US7906628B2Targeting proteins to deliver therapeutic or diagnostic reagentsUNIV TEXAS·Filed 2007·Granted Mar 15, 2011·3 cites·4 claims
- 0470US7893033B2Targeting proteins to deliver therapeutic or diagnostic reagentsUNIV TEXAS·Filed 2003·Granted Feb 22, 2011·3 cites·8 claims
- 0559US10071147B2Method for enhancing immune response in the treatment of infectious and malignant diseasesTAIPEI VETERANS GENERAL HOSPITAL·Filed 2016·Granted Sep 11, 2018·0 cites·4 claims
- 0658US2024279607A1Pharmaceutical composition comprising modified natural killer cells and antigen-specific t cells, manufacturing method thereof, and method of using the sameFULLHOPE BIOMEDICAL CO LTD·Filed 2023·Application pending·0 cites
- 0741US11684656B2Combination therapy for malignant diseasesTAIPEI VETERANS GENERAL HOSPITAL·Filed 2016·Granted Jun 27, 2023·0 cites·6 claims
- 0839US2011065776A1Method for Treating Hepatitis C InfectionLAN KENG-HSIN·Filed 2010·Application pending·0 cites
- 0937US2020308241A1Novel conjugates and uses thereofLAN KENG LI·Filed 2018·Application pending·0 cites
- 1025US10202432B2Dual targeting drug carrier and application thereofNAT YANG MING UNIVERISTY·Filed 2015·Granted Feb 12, 2019·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Keng-Li Lan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →